A Prospective Study to Evaluate the WP in Comparison to PSG in Patients Suspected of Sleep Disorders

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

600 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-09-19

Study Completion Date

2025-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The current study is a prospective blinded study to collect data regarding the performance of the WP device in detecting sleep disorders. For that purpose, the WP with finger probe and chest sensor will be worn by the subject simultaneous to PSG in a sleep study at the clinical sleep lab. A PSG system will be recording the PSG data.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Sleep Actigraphy in Postural Tachycardia Syndrome (POTS)

NCT00692471

Postural Tachycardia Syndrome Orthostatic Intolerance Sleep Disorders

ACTIVE_NOT_RECRUITING

Assessment of Sleep by WHOOP in Ambulatory Subjects

NCT03692195

Sleep Quality

COMPLETED NA

Efficacy of the Dreem 3S Ambulatory Sleep Monitoring Device for the Evaluation of Narcolepsy

NCT06531876

Narcolepsy Type 1 Hypersomnia Sleep Disorder

ACTIVE_NOT_RECRUITING NA

Verification of Computerized Sleep-wake Analysis in Sleep Disorders

NCT02412527

Sleep-wake Analysis

UNKNOWN

Effects of Stellate Ganglion Block and Superior Cervical Ganglion Block on Sleep and Recovery

NCT05470361

PTSD

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Subjects suspected of having sleep disorders who are referred to a sleep study will be screened for potential participation in the study, according to the inclusion and exclusion criteria. Additionally, patients with comorbidities associated with central sleep apnea may be referred from cardiology related divisions, and screened for participation in the study. Recruited patients will be asked to sign an informed consent form. Subject demographic and medical information will be acquired from the subject himself and/or from the subject's medical chart and will be recorded on the appropriate case report forms.

The subjects will be admitted to the clinical sleep laboratory for one night, during which they will undergo conventional full night PSG recording with the standard PSG channels. The WP with finger probe and chest sensor will be worn by the subject simultaneous to PSG. A PSG system will be recording the signals and manual scoring will be performed blinded - without access to WP data. The WP analysis will be done automatically.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sleep Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age between 12-99
* Subjects that are able to read understand and sign the informed consent form of the study or by parents of subjects that are less than 18 years of age that are referred to undergo an overnight sleep study in the clinical sleep laboratory
* Subjects suspected of having sleep disorders or with comorbidities relevant to central sleep apnea.